Researchers have identified a potential cause of fatigue in patients with neuromuscular diseases such as Duchenne muscular dystrophy. The findings, published this week in Nature, could lead to new treatments that improve the quality of life for these patients.
Patients with neuromuscular disorders experience extreme fatigue after even the mildest of exertion. Kevin Campbell and colleagues find in mice with similar disorders that this is caused by a lack of a particular molecule in the membranes of muscle cells - neuronal nitric oxide synthase (nNOS). The team find a similar deficit in nNOS in tissue samples from patients with a wide range of disorders, suggesting a shared mechanism of fatigue.
In healthy muscles, nNOS signalling widens blood vessels to help them recover faster after exercise. Treating diseased mice with drugs that mimic the effects of nNOS had a similar effect, allowing the mice to regain activity after exercise much faster. The results suggest that a similar strategy could be used to treat patients.
Kevin Campbell (University of Iowa, Iowa City, IA, USA)
Abstract available online.(C) Nature press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking